BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12644889)

  • 41. Morphine-like stimulus effects in the monkey: opioids with antagonist properties.
    Schaefer GJ; Holtzman SG
    Pharmacol Biochem Behav; 1981 Feb; 14(2):241-5. PubMed ID: 6451874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulus properties of opioids with mixed agonist and antagonist activity.
    Holtzman SG
    Fed Proc; 1982 May; 41(7):2328-32. PubMed ID: 6281084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
    Negus SS; Morgan D; Cook CD; Picker MJ
    Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine.
    Spanagel R; Shoaib M
    Neuroscience; 1994 Dec; 63(3):797-804. PubMed ID: 7898679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring naloxone antagonism of discriminative opioid stimulus.
    Krimmer EC; Barry H
    Fed Proc; 1982 May; 41(7):2319-22. PubMed ID: 7042395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Beardsley PM; Balster RL
    Pharmacol Biochem Behav; 1998 Jun; 60(2):507-17. PubMed ID: 9632234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Olmstead MC; Burns LH
    Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats.
    Craft RM; Heideman LM; Bartok RE
    Drug Alcohol Depend; 1999 Jan; 53(2):95-109. PubMed ID: 10080036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of the response rate-decreasing effects of meperidine and morphine by beta-funaltrexamine and naltrexone in squirrel monkeys.
    Hughes CE; Dykstra LA
    Drug Alcohol Depend; 1997 May; 45(3):197-206. PubMed ID: 9179521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.